Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 18 Aug 2026. Factsheet Jun 2026. About · Disclosures
UTI Healthcare Fund - Direct Growth Plan
UTI Mutual FundSectoral Pharma and HealthcareDirectGrowthVery high risk
NAV
₹388.4546
As on 18 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +16.44% | — | — |
| 3 year | +24.22% | — | — |
| 5 year | +16.88% | — | — |
- Sharpe
- 1.19
- Std dev
- 16.65%
- Beta
- 0.96
Returns
From NAVs through 18 Aug 2026
1Y
+16.44%
Total
3Y
+24.22%
p.a.
5Y
+16.88%
p.a.
SI
+16.76%
p.a.
Calendar years
-11.30%2022
+39.56%2023
+44.27%2024
-2.18%2025
+20.79%2026 YTD
Rolling 1-year · 51 overlapping windows
-12.87%avg +18.04%+59.69%
Fund facts
Fund details from the Jun 2026 factsheet
Fund size
₹1,307.98 Cr
Expense ratio
1.21%
Exit load
None
Lock-in
None
BenchmarkBSE Healthcare TRI
Launched01 Jan 2013
Risk levelVery high
StructureOpen Ended
ISININF789F01TO9
Where the money is invested
Split by asset type.
By asset type
Equity95.05%
Cash4.95%
What the fund holds
44 holdings · portfolio as on 29 Jun 2026
- 8.54%Sun Pharmaceuticals Industries LtdHealthcare
- 5.08%Ajanta Pharma LtdHealthcare
- 4.95%Net Current Assets
- 4.74%Divi's Laboratories LtdHealthcare
- 4.11%Gland Pharma LtdHealthcare
- 4.02%Caplin Point Laboratories LtdHealthcare
- 3.77%Lupin LtdHealthcare
- 3.52%Apollo Hospitals Enterprise LtdHealthcare
- 3.14%Alkem Laboratories LtdHealthcare
- 3.01%Dr Reddy's Laboratories LtdHealthcare
Concentration
Top 5 weight
27.42%
Top 10 weight
44.87%
Avg turnover
43.33%
Risk and quality measures
How steady the returns have been.
Return quality
Sharpe
1.19
Better than category avg 0.98
Sortino
1.87
Return per unit of downside risk
Alpha
2.69
Return above the benchmark
Information ratio
0.36
Consistency of outperformance
Risk
Std deviation
16.65%
How much returns swing
Beta
0.96
Below category avg 0.95
R-squared
96.1%
How closely it tracks the benchmark
Who manages this fund
1 fund manager
- KGKamal Gada3.8 years in the industryRuns 2 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare- ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare- Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
Rate
+24.22%
Invested
₹6,00,000
Illustrated
₹25,27,742
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- directIDCWUTI Healthcare Fund - Direct IDCW PayoutNAV ₹256.22
- regularIDCWUTI Healthcare Fund - IDCW Payout PlanNAV ₹226.62
- regularGrowthUTI Healthcare Fund - Growth PlanNAV ₹293.23
FAQ
What is UTI Healthcare Fund - Direct Growth Plan NAV today?
- The latest NAV of UTI Healthcare Fund - Direct Growth Plan is ₹388.4546 as on 18 Aug 2026.
How has UTI Healthcare Fund - Direct Growth Plan performed vs its category?
- 1-year return +16.44%. Past performance does not guarantee future returns.
What are the returns of UTI Healthcare Fund - Direct Growth Plan?
- Trailing returns from published NAVs: 1 year +16.44%, 3 year +24.22% a year, 5 year +16.88% a year, since our first NAV +16.76% a year. Past performance does not guarantee future returns.
How would a SIP in UTI Healthcare Fund - Direct Growth Plan have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +24.22%. It is not a forecast.
What is the expense ratio and fund size of UTI Healthcare Fund - Direct Growth Plan?
- For UTI Healthcare Fund - Direct Growth Plan, the expense ratio is 1.21% and fund size (AUM) is ₹1,307.98 Cr.
What is the ISIN of UTI Healthcare Fund - Direct Growth Plan?
- The ISIN for UTI Healthcare Fund - Direct Growth Plan is INF789F01TO9.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.